SCIDに対する遺伝子療法の有効性は確認されています
Marina Cavazzana-Calvo1, Alain Fischer
1Département de Biothérapie, Hôpital Necker-Enfants Malades, 75015 Paris, France. m.cavazzana@nck.ap-hop-paris.fr
Lancet (London, England)
|December 22, 2004
まとめ
No abstract available in PubMed .
さらに関連する動画
関連する概念動画
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.


